Building access to the Regenstrief Institute is restricted through early 2021. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief Institute research scientist Michael “Mick” Murray, PharmD, MPH, is retiring after decades of groundbreaking work. He has been with the institute for 34 years while pioneering in the field of pharmacoepidemiology. He is the Purdue College of Pharmacy Distinguished Professor of Pharmacy Practice and Endowed Chair of Medication Safety.

Dr. Murray began work at Regenstrief in 1986, holding the first Regenstrief-Purdue fellowship in pharmacoepidemiology. He served as the director of the institute’s Health Data & Epidemiology Section from 1996 to 2004 and as the executive director of the institute’s Center for Healthcare Effectiveness Research from 2010 to 2015 while also directing the Regenstrief Data Core (now known as Regenstrief Data Services).

His research focused on improving medication uses and safety in individuals with chronic disease. Dr. Murray developed pharmacy services to improve drug therapy in older adults with chronic disorders and applied pharmacoepidemiology using large population computer databases.

Through more than 130 publications, Dr. Murray substantively advanced the understanding of medication safety, adherence and epidemiology in burdensome medical conditions such as heart failure, hypertension, and dementia.

Dr. Murray is a member of the National Academy of Medicine’s Clinical Effectiveness Research Innovation Collaborative and the World Health Organization’s Committee for Global Patient Safety Challenge on Medication Safety. He has served on the boards of the American Society for Clinical Pharmacology & Therapeutics, the International Society for Pharmacoepidemiology (in which he is a fellow and charter member), and the United States Pharmacopeia. He has won countless awards, including Indiana Public Health Foundation’s Excellence in Health Science Research Award and John M. Eisenberg Memorial Lectureship on Therapeutics Research from the Agency for Health Care Research and Quality.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313
Cindy Fox Aisen
Regenstrief Institute
caisen@regenstrief.org
(317) 843-2275

Related News

Mar 05, 2021 • News
More than 2/3 of Indiana nursing home staff would take COVID-19 vaccine
Educating staff is crucial for increasing uptake and achieving desired results In a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future, according to a study led by researchers from Regenstrief Institute, Indiana University…
Continue Reading >
Mar 02, 2021 • News
Second online survey launched by Regenstrief, IU to help gather COVID-19 data
Data shows willingness to get vaccine, reaches at-risk population   Regenstrief Institute and Indiana University launched a second online survey to gather data about COVID-19 symptoms, behaviors, and vaccine attitudes following the success of a pilot project. The questionnaire allows researchers to gather large quantities of data from across the U.S. quickly.   The pilot survey went online in April 2020 with questions about individuals’ COVID-19 symptoms, general location and travel history. It was distributed via banner ads on…
Continue Reading >